Ensayos clínicos

Inclusion Criteria:

• Age ≥18 years, male or female
• Diagnosis: multiple myeloma undergoing Autologous Stem Cell Transplantation (SCT)  
• Planning to receive conditioning chemotherapy with Melphalan (140 – 200 mg/m2) alone for autologous stem cell transplantation and standard prophylactic antibiotics treatment.
• Can drink 200ml of mannitol and agrees to undergo stool, urine, and blood checks 3 times during the study.

Exclusion Criteria:

• Patients with history of inflammatory bowel disease will be excluded from the study.
• Patients with prior GI tract surgical (small or large bowel) resections
• The concurrent presence of systemic light chain amyloidosis
• Women who are pregnant or breast-feeding
• Presence of any condition that the Investigator believes would put the subject at risk or would preclude the patient from successfully completing all aspects of the trial.